ISAAC BECKLER
Prescription History 1881237956
Physician Assistant in Pittsburgh, PA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for ISAAC BECKLER, an active Physician Assistant specialist practicing in Pittsburgh, PA. Our medical registry currently tracks 13 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 820 documented patient claims. Among these therapy options, the most frequently utilized medication is Tamsulosin Hcl, which accounts for 302 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other PA PrescribersVs. PA Avg |
|---|---|---|---|
| Tamsulosin Hcl | 302 | $22.36 | ▲ More than typical |
About Tamsulosin Hcl: Tamsulosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Tamsulosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. A sulfonamide derivative and adrenergic alpha-1 receptor antagonist that is used to relieve symptoms of urinary obstruction caused by BENIGN PROSTATIC HYPERPLASIA. In 2024, this provider wrote 302 Medicare prescriptions for Tamsulosin Hcl, about 3.1 times the volume of the typical Pennsylvania prescriber of this medication (97.5). Medicare paid an average of $22.36 per fill, versus $17.08 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 655.9 30-Day Fills standardized to 30-day supplies 19,565 Days of Medication total across all patients in 2024 | |||
| Finasteride | 154 | $13.28▼ below PA avg | ▲ More than typical |
About Finasteride: Finasteride is used to shrink an enlarged prostate (benign prostatic hyperplasia or BPH) in adult men. Show more ▾ It may be used alone or taken in combination with other medications to reduce symptoms of BPH and may also reduce the need for surgery. Finasteride may improve symptoms of BPH and provide benefits such as decreased urge to urinate, better urine flow with less straining, less of a feeling that the bladder is not completely emptied, and decreased nighttime urination. This medication works by decreasing the amount of a natural body hormone (DHT) that causes growth of the prostate. Finasteride is not approved for prevention of prostate cancer. It may slightly increase the risk of developing a very serious form of prostate cancer. Talk to your doctor about the benefits and risks. Women and children should not use this medication. An orally active 3-OXO-5-ALPHA-STEROID 4-DEHYDROGENASE inhibitor. It is used as a surgical alternative for treatment of benign PROSTATIC HYPERPLASIA. In 2024, this provider wrote 154 Medicare prescriptions for Finasteride, about 2.6 times the volume of the typical Pennsylvania prescriber of this medication (59.7). Medicare paid an average of $13.28 per fill, versus $14.22 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 377 30-Day Fills standardized to 30-day supplies 11,269 Days of Medication total across all patients in 2024 | |||
| MyrbetriqMirabegron | 93 | $557.51▼ below PA avg | ▲ More than typical |
About Myrbetriq: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity. A beta3-adrenergic receptor agonist. In 2024, this provider wrote 93 Medicare prescriptions for Myrbetriq, about 2 times the volume of the typical Pennsylvania prescriber of this medication (47.4). Medicare paid an average of $557.51 per fill, versus $570.98 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 121 30-Day Fills standardized to 30-day supplies 3,548 Days of Medication total across all patients in 2024 | |||
| Testosterone Cypionate | 51 | $32.05 | ▲ More than typical |
About Testosterone Cypionate: This medication is used in men who do not make enough of a natural substance called testosterone. Show more ▾ In males, testosterone is responsible for many normal functions, including growth and development of the genitals, muscles, and bones. It also helps cause normal sexual development (puberty) in boys. Testosterone belongs to a class of drugs known as androgens. It works by affecting many body systems so that the body can develop and function normally. Testosterone may also be used in certain adolescent boys to cause puberty in those with delayed puberty. Some brands may also be used to treat certain types of breast cancer in women. A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. In 2024, this provider wrote 51 Medicare prescriptions for Testosterone Cypionate, about 2.3 times the volume of the typical Pennsylvania prescriber of this medication (22). Medicare paid an average of $32.05 per fill, versus $31.76 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 51.5 30-Day Fills standardized to 30-day supplies 1,191 Days of Medication total across all patients in 2024 | |||
| Mirabegron ErMirabegron | 44 | $421.82 | ▲ More than typical |
About Mirabegron Er: This medication is used to treat certain bladder problems (overactive bladder, neurogenic detrusor overactivity). Show more ▾ Overactive bladder is a problem with how your bladder stores urine. Neurogenic detrusor overactivity is a bladder control condition caused by brain, spinal cord, or nerve problems. Symptoms of these conditions may include frequent urination, strong sudden urges to urinate that are hard to control, or involuntary loss of urine (incontinence). Mirabegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder and neurogenic detrusor overactivity. A beta3-adrenergic receptor agonist. In 2024, this provider wrote 44 Medicare prescriptions for Mirabegron Er, about 1.7 times the volume of the typical Pennsylvania prescriber of this medication (26.4). Medicare paid an average of $421.82 per fill, versus $371.88 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 60 30-Day Fills standardized to 30-day supplies 1,786 Days of Medication total across all patients in 2024 | |||
| Alfuzosin Hcl ErAlfuzosin Hcl | 40 | $33.34 | ≈ Typical |
About Alfuzosin Hcl Er: Alfuzosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Alfuzosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. In 2024, this provider wrote 40 Medicare prescriptions for Alfuzosin Hcl Er, about 90% of the volume of the typical Pennsylvania prescriber of this medication (44.6). Medicare paid an average of $33.34 per fill, versus $21.47 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 106.3 30-Day Fills standardized to 30-day supplies 3,190 Days of Medication total across all patients in 2024 | |||
| Bethanechol Chloride | 27 | $42.77▼ below PA avg | ≈ Typical |
About Bethanechol Chloride: This medication is used to treat certain bladder problems such as the inability to urinate or empty the bladder completely due to certain causes (such as surgery, bladder muscle problems). Show more ▾ It works by helping the bladder muscle to squeeze better, thereby improving your ability to urinate. A slowly hydrolyzing muscarinic agonist with no nicotinic effects. Bethanechol is generally used to increase smooth muscle tone, as in the GI tract following abdominal surgery or in urinary retention in the absence of obstruction. It may cause hypotension, HEART RATE changes, and BRONCHIAL SPASM. In 2024, this provider wrote 27 Medicare prescriptions for Bethanechol Chloride, about the same volume as the typical Pennsylvania prescriber of this medication (24.7). Medicare paid an average of $42.77 per fill, versus $51.16 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 31 30-Day Fills standardized to 30-day supplies 930 Days of Medication total across all patients in 2024 | |||
| Testosterone | 24 | $66.02▼ below PA avg | ≈ Typical |
About Testosterone: This medicated gel contains testosterone. Show more ▾ It is used for hormone replacement in men who are not able to produce enough testosterone (for example, due to hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels. Testosterone helps the body to develop and maintain the male sexual characteristics (masculinity), such as a deep voice and body hair. It also helps to maintain muscle and prevent bone loss, and is necessary for natural sexual ability/desire. This drug should not be used by women. A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. In 2024, this provider wrote 24 Medicare prescriptions for Testosterone, about the same volume as the typical Pennsylvania prescriber of this medication (23.5). Medicare paid an average of $66.02 per fill, versus $145.89 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 24.5 30-Day Fills standardized to 30-day supplies 726 Days of Medication total across all patients in 2024 | |||
| Oxybutynin Chloride ErOxybutynin Chloride | 21 | $21.18▼ below PA avg | ▼ Less than typical |
About Oxybutynin Chloride Er: This is a long-acting form of oxybutynin that is used to treat overactive bladder and urinary conditions. Show more ▾ It relaxes the muscles in the bladder to help decrease problems of urgency and frequent urination. Oxybutynin belongs to a class of drugs known as antispasmodics. This medication is also used to treat children 6 years of age and older who have an overactive bladder due to certain nerve disorders (such as spina bifida). In 2024, this provider wrote 21 Medicare prescriptions for Oxybutynin Chloride Er, about half the volume of the typical Pennsylvania prescriber of this medication (35.2). Medicare paid an average of $21.18 per fill, versus $22.21 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 27.9 30-Day Fills standardized to 30-day supplies 617 Days of Medication total across all patients in 2024 | |||
| GemtesaVibegron | 19 | $531.11▼ below PA avg | ▼ Less than typical |
About Gemtesa: This medication is used to treat overactive bladder. Show more ▾ Overactive bladder is a problem with how your bladder stores urine that causes a sudden urge to urinate. The urge may be hard to control, and overactive bladder symptoms may include frequent urination, strong sudden urges to urinate, or involuntary loss of urine (incontinence). Vibegron works by relaxing a certain bladder muscle (detrusor), which helps the bladder hold more urine and lessens symptoms of overactive bladder. A beta3 adrenergic receptor agonist. In 2024, this provider wrote 19 Medicare prescriptions for Gemtesa, about a third of the volume of the typical Pennsylvania prescriber of this medication (50.4). Medicare paid an average of $531.11 per fill, versus $619.07 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 21 30-Day Fills standardized to 30-day supplies 620 Days of Medication total across all patients in 2024 | |||
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $8.16▼ below PA avg | ▼ Less than typical |
About Nitrofurantoin Mono-Macro: This medication is an antibiotic used to treat bladder infections (acute cystitis). Show more ▾ It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections. This medication should not be used in infants younger than 1 month old (see also Precautions section). This drug should not be used to treat infections outside the bladder (including kidney infections such as pyelonephritis or perinephric abscesses). In 2024, this provider wrote 17 Medicare prescriptions for Nitrofurantoin Mono-Macro, about 67% of the volume of the typical Pennsylvania prescriber of this medication (25.2). Medicare paid an average of $8.16 per fill, versus $13.29 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 17 30-Day Fills standardized to 30-day supplies 115 Days of Medication total across all patients in 2024 | |||
| Solifenacin Succinate | 15 | $33.92▼ below PA avg | ▼ Less than typical |
About Solifenacin Succinate: Solifenacin is used to treat an overactive bladder. Show more ▾ By relaxing the muscles in the bladder, solifenacin improves your ability to control your urination. It helps to reduce leaking of urine, feelings of needing to urinate right away, and frequent trips to the bathroom. This medication belongs to the class of drugs known as antispasmodics. A quinuclidine and tetrahydroisoquinoline derivative and selective M3 MUSCARINIC ANTAGONIST. It is used as a UROLOGIC AGENT in the treatment of URINARY INCONTINENCE. In 2024, this provider wrote 15 Medicare prescriptions for Solifenacin Succinate, about half the volume of the typical Pennsylvania prescriber of this medication (35.6). Medicare paid an average of $33.92 per fill, versus $40.55 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the PA average for this medication. 29 30-Day Fills standardized to 30-day supplies 870 Days of Medication total across all patients in 2024 | |||
| Silodosin | 13 | $143.51 | ▼ Less than typical |
About Silodosin: Silodosin is used by men to treat the symptoms of an enlarged prostate (benign prostatic hyperplasia-BPH). Show more ▾ It does not shrink the prostate, but it works by relaxing the muscles in the prostate and the bladder. This helps to relieve symptoms of BPH such as difficulty in beginning the flow of urine, weak stream, and the need to urinate often or urgently (including during the middle of the night). Silodosin belongs to a class of drugs known as alpha blockers. Do not use this medication to treat high blood pressure. An alpha(1a)-adrenoceptor-selective antagonist. In 2024, this provider wrote 13 Medicare prescriptions for Silodosin, about half the volume of the typical Pennsylvania prescriber of this medication (29.2). Medicare paid an average of $143.51 per fill, versus $82.05 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average PA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 25 30-Day Fills standardized to 30-day supplies 750 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for ISAAC BECKLER is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Physician Assistant prescribing approach at this Pittsburgh, PA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among PA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
